Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12621000905864
Ethics application status
Approved
Date submitted
30/03/2021
Date registered
13/07/2021
Date last updated
18/11/2021
Date data sharing statement initially provided
13/07/2021
Type of registration
Prospectively registered
Titles & IDs
Public title
Can community-level strategies improve timely diagnosis of chronic conditions and best-practice care for older Aboriginal and Torres Strait Islander people including dementia?
Query!
Scientific title
Investigating the effect of multi-component, community, health practitioner and system-level strategies on diagnosis of chronic conditions and provision of best-practice care for older Aboriginal and Torres Strait Islander people including dementia
Query!
Secondary ID [1]
297646
0
nil known
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Dementia
322638
0
Query!
Alzheimer's disease
322639
0
Query!
Stroke
322640
0
Query!
Chronic obstructive pulmonary disease
322641
0
Query!
Kidney disease
322642
0
Query!
Diabetes
322643
0
Query!
Coronary heart disease
322644
0
Query!
Hypertension
322645
0
Query!
Depression
322646
0
Query!
Condition category
Condition code
Neurological
310508
310508
0
0
Query!
Dementias
Query!
Neurological
319005
319005
0
0
Query!
Alzheimer's disease
Query!
Neurological
319006
319006
0
0
Query!
Neurodegenerative diseases
Query!
Stroke
319007
319007
0
0
Query!
Ischaemic
Query!
Respiratory
319008
319008
0
0
Query!
Chronic obstructive pulmonary disease
Query!
Renal and Urogenital
319009
319009
0
0
Query!
Kidney disease
Query!
Metabolic and Endocrine
319010
319010
0
0
Query!
Diabetes
Query!
Cardiovascular
319011
319011
0
0
Query!
Coronary heart disease
Query!
Cardiovascular
319012
319012
0
0
Query!
Hypertension
Query!
Mental Health
319013
319013
0
0
Query!
Depression
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
A cluster randomised controlled trial with 16 eligible communities randomised to either (i) a community based multi-component intervention (n=8); or (ii) usual care (n=8).
Interventions: Aboriginal Community Controlled Health Services (ACCHSs) allocated to the intervention condition will receive a 3-year multi-component community-based intervention designed to address barriers to the timely diagnosis of dementia and the provision of best practice care. Intervention components are based on an extensive review of the literature and recommendations of multidisciplinary experts, and will be further refined by the Aboriginal Advisory Group and through a local community consultation and engagement process. Timing of the implementation of each strategy will be determined in consultation with each individual ACCHS. The intervention will be implemented in Years 2-4. Further strategy development, consultation and baseline data collection will occur in the first 12 months (Year 1). A 3-year community-based intervention will commence in Year 2 and will completed at the end of Year 4.
1. Community-level strategies
a) Community information sessions to raise dementia knowledge. Each ACCHS will be supported to hold a series of 1-hour community dementia knowledge sessions in Years 2, 3 and 4 (one session annually). A trained ACCHS staff member will be supported by the research team to deliver the session.
b) Supportive Care Community Networks
The community consultation processes will identify agencies that could form a Supportive Care Network. Likely representation will include those from ACCHSs, hospitals, aged care services, allied healthcare, legal services and Aboriginal people living with chronic disease, their carers and families. Where required ACCHS representatives who facilitate the meetings (4 meetings/year) will be offered facilitation training and consumers will be offered advocacy training. The remit of the Supportive Care Network will be determined in consultation with each Aboriginal Medical Service (AMS) and will reflect the local community needs. Prior to further consultation, it is envisaged that the Supportive Care Network's role will be to ensure coordination of care for older Aboriginal people. This is likely to result in improved communication between community-based organisations and ACCHSs. The Support Care Networks will map and identify gaps in existing referral pathways and communication processes, and problem solve in regards to care for people living with dementia and their carers and families.
c) The development of culturally appropriate and locally tailored information resources.
The community consultation will allow for the identification of knowledge gaps, and local, state and not-for-profit resources (e.g. brochures, websites, apps, online forums) which will be of benefit for the community information sessions and the Supportive Care Networks. Resources will be developed and may include information regarding ageing and the common signs of cognitive impairment, depression, anxiety, diabetes, hypertension, high cholesterol, coronary heart disease (CHD), stroke, COPD, cancer (all types) and kidney disease.
2. Strategies supporting ACCHSs to identify persons with chronic disease & deliver best practice care.
a) GP, Practice Nurse, Aboriginal Health Worker training
During the consultation process, we will invite ACCHS staff to attend a 2-hr meeting, to ascertain educational needs regarding chronic disease, dementia diagnosis and care. Consultation will be conducted in small groups or as one-on-one interviews, via telephone or Zoom. The consultation process will occur during the initial 12-month baseline period, prior to implementation of the community support strategies. Relevant ACCHS staff including GPs, practice nurses and Aboriginal Health workers will receive 1-2 days training in conducting MBS715 health assessments using the tailored 715 template. Training will also cover appropriate management steps for diabetes, anxiety, dementia, depression, hypertension and high cholesterol. Given staff turnover at ACCHSs, refresher training will be repeated each year throughout the C-RCT period to consolidate knowledge and ensure any new staff receive training. Training will be conducted face-to-face or via videoconference by 1) a GP and Aboriginal Health Worker and 2) Communicare support trainer. Training will cover RACGP/NACCHO guidelines in relation to MBS715 health assessments; practical issues for administering these with patients; and the layout and technical features of the MBS715 template. ACCHSs will be reimbursed for the nurse and Aboriginal Health Worker staff time required to complete the training.
b) Embedding cognitive assessment into MBS 715 Health Assessments.
Step one: Each month, an ACCHS staff member will run a tailored PenCAT report to identify active patients aged over 45 years who have not completed a MBS 715 Health Assessment in the previous 12 months. These patients will be triaged based on pre-existing conditions associated with dementia (e.g. diabetes, heart disease) and dementia lifestyle risk factors (e.g. smoking, alcohol misuse). The staff member will contact identified patients and schedule a time for them and their families to come to the clinic and undertake the Assessment.
Step two: An electronic template will be developed and tailored for use by each ACCHS. It will prompt staff to cover relevant items in the MBS 715 screen, including asking the patient and their family members if they have any concerns about the patient’s cognitive functioning. If this is reported, the template will prompt the ACCHS staff member to assess cognitive ability using the Standardised Mini Mental State Examination (SMMSE). The MBS715 Health Assessment can take up to one hour to complete.
Step three: GPs will review the completed health assessment. The GP will undertake further assessment of patients who have scored under 24 on the SMMSE regarding potential causes of suggested cognitive impairment. If a patient is diagnosed with dementia, a Care Management Plan will be developed.
c) Electronic templates in Medical Director/Communicare for: (i) Referral to My Aged Care.
To overcome barriers such as lack of time and knowledge of services available and how to access them, an electronic template will be developed for GPs using their usual medical practice software. The template will include the initial assessment questions asked by My Aged Care staff that determines if the patient will progress to a formal assessment by the Regional Support Services (RAS) or the Aged Care Assessment Team (ACAT). The Case Manager will log the referral on the My Aged Care website to commence the assessment process.
(ii) Dementia management care plan. In line with best care, the GP will develop a dementia management care plan in partnership with each person diagnosed with dementia and their family. The template will include comorbidities, management goals, actions for patient/carers, treatment/referral options, and arrangements to review the plan.
d) Bi-monthly feedback regarding performance.
In collaboration with the Aboriginal Advisory Group, a system change feedback template will be developed and will provide data to each ACCHS regarding: (i) the number and proportion of active patients aged over 45 years who attended the ACCHS in the previous month and had a completed Health Assessment. From this data, the MBS rebate dollar amount received and the potential MBS dollar amount missed will be calculated; and (ii) the number of new confirmed diagnoses of chronic conditions, including dementia recorded in the medical record. ACCHS bi-monthly performance against set targets for the ACCHS will be displayed using text and graphics, and new targets for the next month will be discussed. ACCHSs will be reimbursed for staff time to complete the reports.
3. Strategies to directly support older adults and their families:
A 0.5 FTE Older Persons Care Coordinator, will be appointed at each ACCHS. The Case Manager will act as an advocate and support for older people who have completed an MBS715 health assessment and their families. The role of the care coordinator would be negotiated with the ACCHS. Based on the results of the 715 assessment, the Coordinator will collaborate with the GP, ACCHS staff, and local Aged Care and other services to help ensure access to, and the coordinated delivery of, health and appropriate aged care and other support services.
Query!
Intervention code [1]
313881
0
Behaviour
Query!
Intervention code [2]
320641
0
Treatment: Other
Query!
Intervention code [3]
320642
0
Diagnosis / Prognosis
Query!
Comparator / control treatment
Usual care - ACCHSs allocated to the usual care condition will continue to provide their normal chronic disease identification and care. Both usual care and community support strategy ACCHSs will undertake the same data collection procedures for the baseline assessment (Year 1) and follow up assessment (Year 5).
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
319365
0
Proportion of eligible patients with a diagnosis of dementia recorded in their medical record at follow-up will be compared between community support and usual care communities. The medical records of ACCHSs will be electronically audited using a tailored PenCAT tool.
Query!
Assessment method [1]
319365
0
Query!
Timepoint [1]
319365
0
At baseline and following cessation of the intervention
Query!
Primary outcome [2]
326542
0
Provision of NHMRC recommended care to eligible patients with a recorded diagnosis of dementia in their medical record. A composite score summing together the three indicators of best practice dementia care (presence of a dementia care management plan, referral to community aged care service and a record of an advance care plan) will be calculated for each patient with a recorded diagnosis of dementia. The composite score will be assessed through the review of patient medical records.
Query!
Assessment method [2]
326542
0
Query!
Timepoint [2]
326542
0
At baseline and following cessation of the intervention
Query!
Secondary outcome [1]
391812
0
The change from baseline in health knowledge (percentage of correct items in the dementia knowledge questionnaire) will be compared between Community Support and usual care groups. This analysis will be undertaken separately for clients and staff. As there are no existing dementia knowledge tools specifically for Aboriginal and Torres Strait Islander people, the research team has developed the dementia knowledge questionnaire. The survey has been developed and pilot tested with Aboriginal people and it includes items in the following domains: early signs, diagnostic process, natural history and expectations from a diagnosis.
Query!
Assessment method [1]
391812
0
Query!
Timepoint [1]
391812
0
At baseline and following cessation of the intervention
Query!
Secondary outcome [2]
391813
0
Proportion of patients aged over 45 years who receive a new diagnosis of a chronic condition over a 12-month period. As per Primary Aim 1, the medical records of ACCHSs will be electronically audited using a tailored PenCAT tool. Chronic diseases to be included are depression, anxiety, diabetes, hypertension, hyperlipidaemia (high cholesterol), coronary heart disease (CHD), stroke, COPD, cancer (all types) and kidney disease. This will be assessed as a composite secondary outcome.
Query!
Assessment method [2]
391813
0
Query!
Timepoint [2]
391813
0
At baseline and following cessation of the intervention
Query!
Secondary outcome [3]
391814
0
For those newly diagnosed with a chronic condition, the proportion who have (a) a care management plan developed, (b) monitoring of disease status, and (c) healthy levels for disease management indicators (where relevant). As per Primary Aim 1, the medical records of ACCHSs will be electronically audited using a tailored PenCAT tool. This will be assessed as a composite secondary outcome.
Query!
Assessment method [3]
391814
0
Query!
Timepoint [3]
391814
0
At baseline and following cessation of the intervention
Query!
Secondary outcome [4]
391815
0
Proportion of patients aged over 45 years with an up to date MBS715 Health Assessment. As per Primary Aim 1, the medical records of ACCHSs will be electronically audited using a tailored PenCAT tool.
Query!
Assessment method [4]
391815
0
Query!
Timepoint [4]
391815
0
At baseline and following cessation of the intervention
Query!
Secondary outcome [5]
391816
0
Proportion of patients aged over 45 years who have received repeated MBS715 assessments at 12 monthly intervals. As per Primary Aim 1, the medical records of ACCHSs will be electronically audited using a tailored PenCAT tool.
Query!
Assessment method [5]
391816
0
Query!
Timepoint [5]
391816
0
At baseline and following cessation of the intervention
Query!
Eligibility
Key inclusion criteria
ACCHSs in NSW and QLD are eligible to participate if they have: (i) a minimum of 500 patients aged over 45 years of age (ii) at least one GP; and (iii) a practice nurse, Aboriginal Health Worker or other health worker.
To be eligible for inclusion in the PenCAT report and manual audit of electronic records, individuals must: have attended the ACCHS at least once in the 12-month baseline and/or follow-up period; be aged 45 years and older; and be community-dwelling.
To be eligible for inclusion in the dementia knowledge survey: individuals must be aged over 18 years, not diagnosed with dementia, able to complete the survey in English and either attending an ACCHS or a clinical staff member of an ACCHS.
Query!
Minimum age
45
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
None
Query!
Study design
Purpose of the study
Diagnosis
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Central randomisation by cluster (site)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Randomization will be performed using a free online blocked randomizer
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Primary Aims:
Increasing timely diagnosis of dementia.
Data will be analysed using mixed effects logistic regression analysis and the model will include fixed effects for experimental group, cluster-level variables (including the proportion of eligible patients with a dementia diagnosis at baseline), individual-level patient characteristics (age, gender, and other comorbidities), and will account for the clustered design with a random site-specific intercept. A previous Australian study assessing dementia prevalence estimated a prevalence of 3.7%. However, this was based on multiple health related records and thus the rate of recorded dementia in ACCHS records is expected to be substantially lower. Correspondence with a large NSW-based ACCHS indicated only 1% of current patients aged >45 years had a diagnosis of dementia. Based on this, we conservatively estimate that 2% of eligible patients from usual care communities will have a diagnosis recorded in the medical record at follow-up, compared to 5% of patients from intervention communities. Using an intra-cluster correlation (ICC) of 0.01 and a significance threshold of 0.05, a sample size of 3,600 patients across 8 clusters per arm (average 400 clients per clinic) will provide 80% power to detect a difference of this size. This would equate to minimum of 110 additional people receiving a dementia diagnosis in the intervention ACCHSs, and if extrapolated to all Aboriginal people aged 45 years and over in Australia would result in 3673 more Aboriginal people receiving a timely dementia diagnosis. We believe a ICC value of 0.01 is consistent with similar outcomes found in different populations. However, the proposed sample size could detect a between-group difference in dementia prevalence of 6% with an ICC as large as 0.03.
Primary Aim 2: Increasing provision of best practice care.
A composite score summing together the three indicators of best practice dementia care will be calculated for each patient with a recorded diagnosis of dementia. The odds of receiving a higher number of care items will be compared between people diagnosed with dementia in the community support and usual care groups using an ordinal logistic mixed effects model with fixed and random effects as described above. In the event that the assumptions for this model are not satisfied, a multinomial mixed effects model will be used to estimate between-group differences. Assuming that 2% of the usual care group, and 5% of the community support group will have a recorded diagnosis of dementia (based on estimated prevalence from aim 1), allowing for a design effect of 1.1 there will be an effective sample size of n=40 in the usual care group and n=130 in the community support group. Assuming 10% of those in usual care receive all three care items (the proportion that have 0, 1 or 2 items are 10%, 50% and 30% respectively, based on discussion with content experts about the current standard of care), the study will have 80% power to detect an increase of 15% in the proportion that receive all three care items between the community support and usual care group (with proportion that receive 0, 1 or 2 items as 5%, 25% and 25% respectively) with a 5% significance threshold.
Secondary Aim 1: The change from baseline health knowledge (percentage of correct items in the dementia knowledge questionnaire) will be compared between treatment groups at follow-up using mixed effects regression models. This analysis will be undertaken separately for clients and staff.
Clients: Assuming there will be on average 100 patients aged over 18 attending each ACCHS for a one month period of baseline and at post community support, and 70% of these consent to be in the study, allowing for an intraclass correlation of 0.01, there will be approximately 80% power to detect a difference of 0.2SD in the percentage of correct knowledge items between groups with 5% significance.
Staff: Based results from the Aboriginal and Torres Strait Islander-specific primary health care OSR and nKPI collections, ACCHSs have an average of 23 full time equivalent health staff. A number of these FTE’s would be expected to be part-time. Assuming a 70% consent rate, it is expected that 184 clinical staff in each of the community support group and the usual care group will complete the survey. Allowing for an intraclass correlation of 0.01, there will be approximately 80% power to detect a difference of 0.2 SD in the percentage of correct knowledge items between groups with 5% significance.
Secondary Aim 2: The change from baseline in the proportion of patients who have a new chronic disease diagnosis will be compared between treatment groups at follow-up using mixed effects regression models..
Secondary Aim 3: The change from baseline for these outcomes will be compared between treatment groups at follow-up using mixed effects regression models.
Secondary Aim 4: The change from baseline in the proportion of eligible patients who had received at least one completed MBS715 Health Assessment in the past 12 months will be compared between Community Support and usual care groups.
Secondary Aim 5: The change from baseline in the proportion of eligible patients who had received MBS715 assessments at 12 month intervals over the last 3 years will be compared between Community Support and usual care groups.
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
1/12/2021
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
1/04/2025
Query!
Actual
Query!
Date of last data collection
Anticipated
30/06/2025
Query!
Actual
Query!
Sample size
Target
6560
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW,QLD
Query!
Funding & Sponsors
Funding source category [1]
302175
0
Government body
Query!
Name [1]
302175
0
National Health and Medical Research Council
Query!
Address [1]
302175
0
16 Marcus Clarke St,
Canberra ACT 2601
Query!
Country [1]
302175
0
Australia
Query!
Primary sponsor type
University
Query!
Name
University of Newcastle
Query!
Address
Health Behaviour Research Collaborative
HMRI Building, Level 4, West Wing
University of Newcastle
Callaghan NSW 2308
Query!
Country
Australia
Query!
Secondary sponsor category [1]
309025
0
None
Query!
Name [1]
309025
0
Query!
Address [1]
309025
0
Query!
Country [1]
309025
0
Query!
Other collaborator category [1]
280590
0
University
Query!
Name [1]
280590
0
University of Newcastle's Priority Research Centre for Health Behaviour
Query!
Address [1]
280590
0
Health Behaviour Research Collaborative
HMRI Building, Level 4, West Wing
University of Newcastle
Callaghan NSW 2308
Query!
Country [1]
280590
0
Australia
Query!
Other collaborator category [2]
280591
0
Other
Query!
Name [2]
280591
0
Hunter Medical Research Institute (HMRI)
Query!
Address [2]
280591
0
Lot 1 Kookaburra Circuit,
New Lambton Heights, NSW 2305
Query!
Country [2]
280591
0
Australia
Query!
Other collaborator category [3]
280592
0
University
Query!
Name [3]
280592
0
Menzies School of Health Research
Query!
Address [3]
280592
0
Red 9, Casuarina campus,
University Drive North, Casuarina NT 0811
Query!
Country [3]
280592
0
Australia
Query!
Other collaborator category [4]
280594
0
University
Query!
Name [4]
280594
0
James Cook University
Query!
Address [4]
280594
0
14-88 McGregor Road
Smithfield, Cairns, QLD 4878
Query!
Country [4]
280594
0
Australia
Query!
Other collaborator category [5]
280595
0
Commercial sector/Industry
Query!
Name [5]
280595
0
Northern Territory Department of Health
Query!
Address [5]
280595
0
87 Mitchell St,
Darwin City NT 8000
Query!
Country [5]
280595
0
Australia
Query!
Other collaborator category [6]
280596
0
University
Query!
Name [6]
280596
0
University of Sydney
Query!
Address [6]
280596
0
Camperdown NSW 2006
Query!
Country [6]
280596
0
Australia
Query!
Other collaborator category [7]
280597
0
University
Query!
Name [7]
280597
0
University of Technology of Sydney
Query!
Address [7]
280597
0
15 Broadway St
Ultimo NSW 2007
Query!
Country [7]
280597
0
Australia
Query!
Other collaborator category [8]
280598
0
Other
Query!
Name [8]
280598
0
Maari Ma Health
Query!
Address [8]
280598
0
428 Argent St,
Broken Hill NSW 2880
Query!
Country [8]
280598
0
Australia
Query!
Other collaborator category [9]
280599
0
University
Query!
Name [9]
280599
0
University of Melbourne
Query!
Address [9]
280599
0
Parkville, VIC 3010
Query!
Country [9]
280599
0
Australia
Query!
Other collaborator category [10]
281658
0
Other
Query!
Name [10]
281658
0
Durri Aboriginal Corporation Medical Service
Query!
Address [10]
281658
0
15-19 York Lane
Kempsey NSW 2440
Query!
Country [10]
281658
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
302857
0
Aboriginal Health and Medical Research Council Human Research Ethics Committee
Query!
Ethics committee address [1]
302857
0
66 Wentworth Ave,
Surry Hills NSW 2010
Query!
Ethics committee country [1]
302857
0
Australia
Query!
Date submitted for ethics approval [1]
302857
0
30/04/2019
Query!
Approval date [1]
302857
0
19/07/2019
Query!
Ethics approval number [1]
302857
0
1518/19
Query!
Ethics committee name [2]
302892
0
University of Newcastle Human Research Ethics Committee
Query!
Ethics committee address [2]
302892
0
Research & Innovation Services
Research Integrity Unit
The University of Newcastle
University Drive
Callaghan NSW 2308
Query!
Ethics committee country [2]
302892
0
Australia
Query!
Date submitted for ethics approval [2]
302892
0
26/07/2019
Query!
Approval date [2]
302892
0
31/07/2019
Query!
Ethics approval number [2]
302892
0
Query!
Summary
Brief summary
This project will test the effectiveness of a community intervention designed to increase the proportion of Aboriginal people who receive a timely diagnosis of dementia and receive best practice care. It will address community, healthcare system, and patient and family level barriers to care, and determine the impact of these strategies on quality of life and depression for Aboriginal people living with dementia and other chronic disease and their carers. ACCHSs allocated to the intervention condition will receive a 3 year multi-component community-based intervention designed to address barriers to the timely diagnosis of dementia and other chronic conditions and the provision of best practice care. If found to be effective, the community-based ACCHS focus will allow the adoption of the strategies by Aboriginal communities across Australia.
Study Hypothesis: A three-year community support strategy implemented at ACCHSs will increase the proportion of Aboriginal people who receive a timely diagnosis of dementia and receive best practice care.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
91626
0
Prof Rob Sanson-Fisher
Query!
Address
91626
0
Health Behaviour Research Collaborative
HMRI Building, Level 4, West Wing
University of Newcastle
Callaghan NSW 2308
Query!
Country
91626
0
Australia
Query!
Phone
91626
0
+61 02 4042 0713
Query!
Fax
91626
0
Query!
Email
91626
0
[email protected]
Query!
Contact person for public queries
Name
91627
0
Dr Megan Freund
Query!
Address
91627
0
Health Behaviour Research Collaborative
HMRI Building, Level 4, West Wing
University of Newcastle
Callaghan NSW 2308
Query!
Country
91627
0
Australia
Query!
Phone
91627
0
+61 02 40420834
Query!
Fax
91627
0
Query!
Email
91627
0
[email protected]
Query!
Contact person for scientific queries
Name
91628
0
Dr Megan Freund
Query!
Address
91628
0
Health Behaviour Research Collaborative
HMRI Building, Level 4, West Wing
University of Newcastle
Callaghan NSW 2308
Query!
Country
91628
0
Australia
Query!
Phone
91628
0
+61 02 40420834
Query!
Fax
91628
0
Query!
Email
91628
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Individual participant data will not be shared in order to preserve participant confidentiality. Data is the property of Aboriginal communities that are part of the research. We do not have ethics approval to share individual level data publicly.
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF